<!DOCTYPE html><html lang="en"><head><meta name="generator" content="Scully 0.0.0">
  <meta charset="utf-8">
  <title>NgxGardSkully 123</title>
  <base href="/">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <link rel="icon" type="image/x-icon" href="favicon.ico">
<link rel="stylesheet" href="styles.4cdd1989b7928c8b693d.css"><style>body,html{overflow-x:hidden}@media (max-width:991.98px){.offcanvas-collapse{position:fixed;top:56px;bottom:0;left:100%;width:100%;padding-right:1rem;padding-left:1rem;overflow-y:auto;visibility:hidden;background-color:#343a40;transition:transform .3s ease-in-out,visibility .3s ease-in-out}.offcanvas-collapse.open{visibility:visible;transform:translateX(-100%)}}.nav-scroller{position:relative;z-index:2;height:2.75rem;overflow-y:hidden}.nav-scroller .nav{display:flex;flex-wrap:nowrap;padding-bottom:1rem;margin-top:-1px;overflow-x:auto;color:hsla(0,0%,100%,.75);text-align:center;white-space:nowrap;-webkit-overflow-scrolling:touch}.nav-underline .nav-link{padding-top:.75rem;padding-bottom:.75rem;font-size:.875rem;color:#6c757d}.nav-underline .nav-link:hover{color:#007bff}.nav-underline .active{font-weight:500;color:#343a40}.text-white-50{color:hsla(0,0%,100%,.5)}.bg-purple{background-color:#6f42c1}.lh-100{line-height:1}.lh-125{line-height:1.25}.lh-150{line-height:1.5}.splitter{margin-left:20px;margin-right:20px;display:inline-block;font-size:20px;transform:scaleX(.3)}.banner{background-color:#1b5b76;height:116px;background-image:url(https://rarediseases.info.nih.gov/content/images/banner-touch-diseases.jpg);background-repeat:no-repeat;background-position:100%}.search-ct{top:40px;left:30px}.footer{background:#d3d3d3;height:230px}.footer-links{padding-top:20px}.footer-text{margin-top:30px;text-align:center}.input-group-text{cursor:pointer}</style><style></style><script>window['ScullyIO']='generated';</script></head>
<body scully-version="0.0.0">
  <app-root ng-version="10.0.14"><nav class="navbar navbar-dark sticky-top bg-dark flex-md-nowrap p-0 shadow"><span class="shrink-width"><ul class="navbar-nav px-3 list-inline"><li class="nav-item text-nowrap list-inline-item"><span href="#" class="nav-link">U.S. Department of Health &amp; Human Services <span class="splitter"> &gt; </span> National Institutes of Health <span class="splitter"> &gt; </span> NCATS</span></li></ul></span></nav><div class="shrink-width"><div class="nav-scroller bg-white shadow-sm justify-content-center"><nav class="nav nav-underline"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases">Diseases</a><a routerlink="/help" routerlinkactive="active" class="nav-link" href="/help">Guides</a><a routerlink="/news" routerlinkactive="active" class="nav-link" href="/news">News</a><a routerlink="/about" routerlinkactive="active" class="nav-link" href="/about">About GARD</a><a routerlink="/espanol" routerlinkactive="active" class="nav-link" href="/espanol">En Espan√µl</a></nav></div><form novalidate="" class="ng-untouched ng-pristine ng-valid"><div class="banner"><div class="col-md-6 search-ct"><div class="input-group mb-3"><input formcontrolname="search" type="text" placeholder="Search for Diseases, Organizations, News and More..." aria-label="Search for Diseases, Organizations, News and More..." aria-describedby="basic-addon2" class="form-control ng-untouched ng-pristine ng-valid"><span class="input-group-text">GO</span></div></div></div></form><div class="container-fluid"><router-outlet></router-outlet><app-disease-details><div class="row"><div class="col-md-3"><nav><div class="sidebar-sticky pt-3"><ul class="nav flex-column"><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Browse A-Z </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> Find Diseases By Category </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> List of FDA Orphan Drugs </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> GARD Information Navigator </a></li><li class="nav-item"><a routerlink="/diseases" routerlinkactive="active" class="nav-link active" href="/diseases"> FAQs About Rare Diseases </a></li></ul></div></nav></div><main role="main" class="col-md-9"><div class="d-flex justify-content-between flex-wrap flex-md-nowrap align-items-center pt-3 pb-2 mb-3 border-bottom"><h1 class="h2">Disease # 10915 - X-linked lymphoproliferative syndrome</h1></div><div><p><b>Other Names: </b>XLP, X-linked lymphoproliferative disease, Lymphoproliferative disease, X-linked, XLPD, Duncan disease, Epstein Barr virus infection, familial fatal, EBV infection, severe, susceptibility to, EBVS, X-linked progressive combined variable immunodeficiency 5, Purtilo syndrome</p><p><b>Categories: </b><span> Congenital and Genetic Diseases</span><span> Immune System Diseases</span><span> Rare Cancers</span><!----></p><p><b>This disease is grouped under: </b>T cell immunodeficiency primary</p><p><b>Summary: </b><span><strong>X-linked lymphoproliferative syndrome (XLP)&nbsp;</strong>is an immune system&nbsp;disorder that occurs almost exclusively in males. People with XLP have an increased risk of infection because their body cannot properly regulate the number of immune system cells (<a href="http://ghr.nlm.nih.gov/glossary=lymphocyte" target="_blank">lymphocytes</a>) and blood cells. The  symptoms associated with XLP vary from person to person, and even among family members. In most cases, symptoms begin anywhere from 6 months of age to 10 years of age.[14614] XLP generally has two subtypes, which are caused by mutations in different genes:[14615][5298]
<ul>
    <li><strong>XLP1</strong> is mainly characterized by an inappropriate immune response to <a href="https://www.cdc.gov/epstein-barr/about-ebv.html" target="_blank">Epstein-Barr virus (EBV) infection</a>, leading to <a href="https://rarediseases.info.nih.gov/diseases/6589/hemophagocytic-lymphohistiocytosis" target="_blank">hemophagocytic lymphohistiocytosis</a> (HLH) or severe <a href="https://www.cdc.gov/epstein-barr/about-mono.html" target="_blank">mononucleosis</a>; dysgammaglobulinemia; and lymphoproliferative disease (malignant lymphoma).</li>
    <li><strong>XLP2</strong> is usually characterized by HLH (often associated with EBV), dysgammaglobulinemia, and <a href="https://www.mayoclinic.org/diseases-conditions/inflammatory-bowel-disease/symptoms-causes/syc-20353315" target="_blank">inflammatory bowel disease</a>&nbsp;(colitis). People with XLP2 have not been known to develop lymphoma.</li>
</ul>
<p>Signs and symptoms of HLH include fever, enlarged lymph nodes and spleen, skin rashes, and problems with the lungs, digestive system, liver, and nervous system.[5298][14867] The heart, kidneys, or other organs may also be affected.[5298] Mononucleosis may cause fatigue; fever; an inflamed and sore throat; enlarged lymph nodes, liver, and spleen; and symptoms of anemia.[14614][14868] Dysgammaglobulinemia causes an increased risk of recurrent infections.[5298]<br>
<br>
XLP1 is caused by mutations in the <em><a href="https://ghr.nlm.nih.gov/gene/SH2D1A" target="_blank">SH2D1A</a></em> gene, and XLP2 is caused by mutations in the <em><a href="https://ghr.nlm.nih.gov/gene/XIAP" target="_blank">XIAP</a></em> gene. Inheritance is X-linked recessive. However, in rare cases, females with a mutation on one copy of the responsible gene develop symptoms of XLP.[5298] A diagnosis of either type of XLP can be confirmed with genetic testing.[14615] Of note, there have been males with mutations known to cause XLP that have not developed symptoms.[14615]<br>
<br>
The only cure for XLP is <a href="https://www.cancer.gov/publications/dictionaries/cancer-terms/def/allogeneic-stem-cell-transplantation" target="_blank">allogeneic hematopoietic cell transplantation</a>, which should be considered as early as possible. Treatment of XLP-related HLH may include immunosuppressive agents (such as steroids and <a href="https://www.cancer.gov/about-cancer/treatment/drugs/etoposide" target="_blank">etoposide</a> or <a href="https://www.mayoclinic.org/drugs-supplements/antithymocyte-globulin-rabbit-intravenous-route/description/drg-20061948" target="_blank">anti-thymocyte globulin</a>), and <a href="https://medlineplus.gov/druginfo/meds/a607038.html" target="_blank">rituximab</a> when HLH is associated with EBV infection. Hypogammaglobulinemia is treated with <a href="https://www.aaaai.org/conditions-and-treatments/conditions-dictionary/immunoglobulin-(IgG)-replacement-therapy" target="_blank">IVIG replacement therapy</a>, and lymphoma is treated with standard chemotherapy. Inflammatory bowel disease is treated with immunosuppression.[14615]<br>
<br>
Without treatment, many people with XLP do not survive beyond childhood, usually due to HLH.[5298] The average age of death for males has been reported as 11 years (with a range of 2-69 years) for XLP1, and 16 years (with a range of 1-52 years) for XLP2.[14615]</p></span></p><div><b>Organizations: </b><ul><li><span><a href="org.url">Jeffrey Modell Foundation</a></span><br><span>780 Third Ave</span><br><span>New York NY, 10017</span><br><!----><!----></li><li><span><a href="org.url">Immune Deficiency Foundation</a></span><br><span>110 West Road, Suite 300</span><br><span>Towson MD, 21204</span><br><!----><!----></li><li><span><a href="org.url">XLP Research Trust</a></span><br><span>60 Winchester Road</span><br><span> , </span><br><!----><!----></li><li><span><a href="org.url">Immune Deficiencies Foundation Australia</a></span><br><span>PO Box 969</span><br><span> , </span><br><!----><!----></li><!----></ul></div><div><b>Learn More</b><ul><li><span>Online Mendelian Inheritance in Man (OMIM) is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br>
<a href="http://www.omim.org/308240" target="_blank">OMIM: X-linked lymphoproliferative syndrome 1</a><br><a href="http://www.omim.org/300635" target="_blank">OMIM: X-linked lymphoproliferative syndrome 2</a><br></span></li><li><span><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%22x-linked%20lymphoproliferative%20disease%22%5BTIAB%5D" target="_blank">PubMed</a> is a searchable database of medical literature and lists journal articles that discuss X-linked lymphoproliferative syndrome. Click on the link to view a sample search on this topic.</span></li><li><span><a href="http://clinicaltrials.gov/search/condition=%22X-linked+lymphoproliferative+disease%22" target="_blank">ClinicalTrials.gov</a> lists trials that are related to X-linked lymphoproliferative syndrome. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br>
<br>
<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em></span></li><li><span><a href="http://ghr.nlm.nih.gov/condition/x-linked-lymphoproliferative-disease" target="_blank">MedlinePlus Genetics</a> contains information on X-linked lymphoproliferative syndrome. This website is maintained by the National Library of Medicine.<br>
</span></li><li><span>The <a href="http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/729/viewAbstract" target="_blank">National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br>
</span></li><li><span><a href="http://emedicine.medscape.com/article/203780-overview" target="_blank">Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br>
</span></li><li><span>The <a href="https://secure.ssa.gov/apps10/poms.nsf/lnx/0423022346" target="_blank">Social Security Administration</a> has included this condition in their Compassionate Allowances Initiative. This initiative speeds up the processing of disability claims for applicants with certain medical conditions that cause severe disability. More information about <a href="http://www.ssa.gov/compassionateallowances/index.htm" target="_blank">Compassionate Allowances</a> and <a href="https://www.ssa.gov/benefits/disability/" target="_blank">applying for Social Security disability</a> is available online.</span></li><li><span><a href="http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&amp;Expert=2442" target="_blank">Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br>
</span></li><li><span><a href="http://www.ncbi.nlm.nih.gov/books/NBK1406/" target="_blank">GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br>
</span></li><li><span><a href="http://www.orpha.net/consor/cgi-bin/ResearchTrials_ResearchProjects_Simple.php?lng=EN&amp;LnkId=275&amp;Typ=Pat" target="_blank">Orphanet</a> lists European clinical trials, research studies, and patient registries enrolling people with this condition.&nbsp;</span></li><li><span><a href="http://www.orpha.net/consor/cgi-bin/ClinicalLabs_Search_Simple.php?lng=EN&amp;LnkId=275&amp;Typ=Pat" target="_blank">Orphanet</a> lists international laboratories offering diagnostic testing for this condition.</span></li><li><span>The <a href="http://www.merckmanuals.com/professional/immunology_allergic_disorders/immunodeficiency_disorders/x-linked_lymphoproliferative_syndrome.html" target="_blank">Merck Manuals Online Medical Library</a> provides information on this condition for patients and caregivers.&nbsp;</span></li><li><span>The <a href="https://monarchinitiative.org/disease/OMIM:308240" target="_blank">Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch‚Äôs tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.</span></li><li><span>Panchal N, Booth C, Cannons JL, Schwartzberg PL. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5893764/">X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.</a> Front Immunol. 2018; 9: 666.</span></li><li><span>A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with X-linked lymphoproliferative syndrome. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href="https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries" target="_blank">Learn more about registries</a>.<br>
<br>
Registries for&nbsp;X-linked lymphoproliferative syndrome:<br>
<a href="https://usidnet.org/about-the-registry/patient-participation/" target="_blank">United States Immunodeficiency Network (USIDENT) Registry</a><br>&nbsp;</span></li><!----></ul></div></div></main><!----></div></app-disease-details><!----></div></div><div class="footer"><div class="shrink-width"><div class="footer-links row align-items-center"><div class="col"><a href="/" target="_self">GARD Home</a></div><div class="col"><a href="http://ncats.nih.gov/">NCATS Home</a></div><div class="col"><a href="javascript: void(0)">Site Map</a></div><div class="col"><a href="javascript: void(0)">Browse Glossary A-Z</a></div><div class="col"><a href="javascript: void(0)">Privacy Notice</a></div><div class="col"><a href="javascript: void(0)">Disclaimer</a></div><div class="col"><a href="javascript: void(0)">Accessibility</a></div><div class="col"><a href="javascript: void(0)">FOIA </a></div><div class="col"><a href="javascript: void(0)">OIG</a></div></div><div class="footer-text"><p> If you have problems viewing PDF files, download the latest version of <a target="_blank" href="https://get.adobe.com/reader/" class="footer-links">Adobe Reader</a></p><p> For <a f="http://edi.nih.gov/consulting/language-access-program/about" target="_blank" title="Read the plan" class="ext">language access</a> assistance, contact the <a href="mailto: info@ncats.nih.gov" title="E - mail Public Information Officer" class="footer-links">NCATS Public Information Officer</a></p><p> Genetic and Rare Diseases Information Center (GARD) - PO Box 8126, Gaithersburg, MD 20898-8126 - Toll-free: 1-888-205-2311 </p></div></div></div></app-root>
<script src="runtime.e227d1a0e31cbccbf8ec.js" defer=""></script><script src="polyfills.1aefc75bf7d5acb269d2.js" defer=""></script><script src="main.f870601fdb5bc988c829.js" defer=""></script>
<script id="ScullyIO-transfer-state"></script><script src="js/custom.js"></script>

</body></html>